Continuation Study for Latozinemab

Stopped early · Phase 3

Conditions studied: Neurodegenerative Diseases

In brief

Continuation study to provide continued access to latozinemab for participants who have previously participated in a latozinemab study

Key facts

Study ID

NCT06111014

Run by

Alector Inc.

People needed

17

Starts

2023-12-08

Expected to finish

2026-01-07

Last updated by the study team

2026-01-21

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Written informed consent must be obtained and documented (from the participant or, where jurisdictions allow it, from their legal decision maker).
• Has successfully completed participation in their parent latozinemab study.
• Female participants must be nonpregnant and nonlactating.
• Male participants must agree to acceptable contraception use.

You may not qualify if…

• Known history of severe allergic, anaphylactic, or other hypersensitivity reactions to chimeric, human, or humanized antibodies or fusion proteins.
• Clinically significant heart disease, liver disease or kidney disease. History or evidence of clinically significant brain disease other than FTD.

Where it is running

• Dignity Health - Arizona — Phoenix, Arizona, United States
• Mayo Comprehensive Cancer Center - PPDS — Rochester, Minnesota, United States
• Irving Institute for Clinical and Translational Research — New York, New York, United States
• University of Cincinnati Gardner Neuroscience Institute — Cincinnati, Ohio, United States
• University of Pennsylvania — Philadelphia, Pennsylvania, United States
• UZ Leuven — Leuven, Belgium
• Parkwood Institute — London, Ontario, Canada
• Sunnybrook Health Sciences Centre — Toronto, Ontario, Canada
• Groupe Hospitalier Pitié Salpétrière — Paris, France
• Universitätsklinikum Ulm - Leimgrubenweg 12-14 — Ulm, Germany
• IRCCS - Centro S. Giovanni di Dio Fatebenefratelli — Brescia, Italy
• Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico -Via Fracesco Sforza 35 — Milan, Italy
• Azienda Ospedaliero Universitaria Di Modena Policlinico — Modena, Italy
• Erasmus MC-Dr. Molewaterplein 40 — Rotterdam, Netherlands
• Centro Hospitalar E Universitario de Coimbra EPE — Coimbra, Portugal
• Centro Hospitalar Universitário Lisboa Norte, EPE - Hospital de Santa Maria — Lisbon, Portugal
• Karolinska Universitetssjukhuset Huddinge — Huddinge, Sweden
• University College London — London, United Kingdom

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.